Allergan IncAGN:NYQ

2.90 / 1.25%
Real-time price in USDToday's changeShares traded1 year changeBeta
As of Mar 02 2015 20:32 GMT. BATS BZX Real-Time Last Sale


Allergan Inc (AGN:NYQ) set a new 52-week high during today's trading session when it reached 235.81. Over this period, the share price is up 86.54%.

52-week range
Apr 08 2014
Mar 02 2015
Markit short selling activity
Day high235.82
Day low233.32
Previous close232.74
Average volume2.04m
Shares outstanding300.24m
Free float298.34m
P/E (TTM)46.34
Market cap69.88bn USD
Annual div (IAD)0.20 USD
Annual div yield (IAD)0.09%
Div ex-dateFeb 25 2015
Div pay-dateMar 20 2015
As of Mar 02 2015 20:32 GMT.BATS BZX Real-Time Quote

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Allergan Inc+2.16 %+6.80 %+44.06 %+85.67 %+292.15 %
S&P 500 INDEX-0.24 %+4.14 %+5.05 %+13.18 %+88.19 %
USA/HEALTH CARE+0.14 %+4.07 %+12.08 %+18.19 %+56.89 %
USA/PHARMACEUTICALS+0.13 %+3.50 %+9.84 %+13.36 %+50.02 %
Data delayed at least 15 minutes, as of Mar 02 2015 20:18 GMT.
© Thomson Reuters Click for restrictions.

Real-time data provided by BATS.

All markets data located on is subject to the FT Terms & Conditions.

All content on is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.